Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

SU-E-T-345: Validation of a Patient-Specific Monte Carlo Targeted Radionuclide Therapy Dosimetry Platform

Journal Article · · Medical Physics
DOI:https://doi.org/10.1118/1.4888678· OSTI ID:22355892
;  [1]
  1. University of Wisconsin, Madison, WI (United States)
Purpose: There is a compelling need for personalized dosimetry in targeted radionuclide therapy given that conventional dose calculation methods fail to accurately predict dose response relationships. To address this need, we have developed a Geant4-based Monte Carlo patient-specific 3D dosimetry platform for TRT. This platform calculates patient-specific dose distributions based on serial CT/PET or CT/SPECT images acquired after injection of the TRT agent. In this work, S-values and specific absorbed fractions (SAFs) were calculated using this platform and benchmarked against reference values. Methods: S-values for 1, 10, 100, and 1000g spherical tumors with uniform activity distributions of I-124, I-125, I-131, F-18, and Ra-223 were calculated and compared to OLINDA/EXM reference values. SAFs for monoenergetic photons of 0.01, 0.1, and 1 MeV and S factors for monoenergetic electrons of 0.935 MeV were calculated for the liver, kidneys, lungs, pancreas, spleen, and adrenals in the Zubal Phantom and compared with previously published values. Sufficient particles were simulated to keep the voxel statistical uncertainty below 5%. Results: The calculated spherical S-values agreed within a few percent of reference data from OLINDA/EXM for each radionuclide and sphere size. The comparison of photon SAFs and electron S-values with previously published values showed good agreement with the previously published values. The S-values and SAFs of the source organs agreed within 1%. Conclusion: Our platform has been benchmarked against reference values for a variety of radionuclides and over a wide range of energies and tumor sizes. Therefore, this platform could be used to provide accurate patientspecific dosimetry for use in radiopharmaceutical clinical trials.
OSTI ID:
22355892
Journal Information:
Medical Physics, Journal Name: Medical Physics Journal Issue: 6 Vol. 41; ISSN 0094-2405; ISSN MPHYA6
Country of Publication:
United States
Language:
English

Similar Records

The Current State of Radiation Dosimetry in Radionuclide Therapy
Journal Article · Wed Jun 15 00:00:00 EDT 2016 · Transactions of the American Nuclear Society · OSTI ID:22991820

Comparison of internal dose estimates obtained using organ-level, voxel S value, and Monte Carlo techniques
Journal Article · Mon Sep 15 00:00:00 EDT 2014 · Medical Physics · OSTI ID:22409600

WE-H-207A-07: Image-Based Versus Atlas-Based Internal Dosimetry
Journal Article · Wed Jun 15 00:00:00 EDT 2016 · Medical Physics · OSTI ID:22679167